The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

U.S. Food and Drug Administration commissioner Marty Makary has appointed former biotech executive George Tidmarsh as the ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

With so few Alzheimer's drugs available, repurposing medications approved for other conditions could be the key to tackling ...

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

Rinsing produce helps remove dirt, bacteria, pesticides, and other chemicals that can get on food during the harvesting and ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

Companies are selling personalized compounded drugs that combine weight loss and erectile dysfunction treatments, but is this safe? No one can say because it’s all “personalized” compounded drugs ...

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

American depositary receipts of RedHill Biopharma climbed after the company said it received positive Food and Drug Administration feedback on its treatment for Crohn's disease. The ADRs were up 24%, ...